Anebulo Pharmaceuticals, Inc. (ANEB)

NASDAQ: ANEB · IEX Real-Time Price · USD
4.19
-0.03 (-0.71%)
Aug 10, 2022 3:58 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Year 2021
Selling, General & Admin
1.34
Research & Development
2.27
Operating Expenses
3.61
Operating Income
-3.61
Interest Expense / Income
0.01
Other Expense / Income
26.63
Pretax Income
-30.25
Net Income
-30.25
Preferred Dividends
8.21
Net Income Common
-38.46
Shares Outstanding (Basic)
14
Shares Outstanding (Diluted)
14
EPS (Basic)
-2.83
EPS (Diluted)
-2.83
Free Cash Flow Per Share
-0.36
EBITDA
-30.24
EBIT
-30.24
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).